The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
The Global Intermittent Catheter Market size is expected to reach $3 billion by 2024, rising at a market growth of 8.9% CAGR during the forecast period (2018 - 2024). Intermittent catheter is a type of urological catheter, and it is used in draining urine from the urinary bladder from individuals who have urological problems. These catheters are made from PVC or vinyl, latex rubber, and silicone materials. Intermittent catheters are majorly used by people with spinal cord injuries or people suffering from urinary incontinence. The key factors driving the growth of intermittent catheters market are growing cases of urinary incontinence and growing number of geriatric population on a global level.
However, highly competitive market environment and limited awareness about the benefits of intermittent catheters are factors that would limit the growth of the market during the forecast period. Based on product, the market is segmented into Non-coated Intermittent Catheters and Coated Intermittent Catheters. Coated Intermittent Catheters is further sub segmented into Hydrophilic, Antimicrobial, and Others Based on category, the market is segmented into Kid Length Catheter, Male Length Catheters, and Female Length Catheter. Based on end user the market is segmented into Hospitals, Ambulatory Surgical Centers, and Medical Research Centers. The indication segment Urinary Incontinence, Spinal Cord Injuries, General Surgery, and Other Indications. Based on Regions, the Intermittent Catheter market segments the market into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The market research report covers the analysis of key stake holders of the Global Intermittent Catheter Market. Key companies profiled in the report include Becton Dickinson Company, B. Braun Melsungen AG, Coloplast Ltd., C. R. Bard, Inc., Hollister Incorporated, Medical Technologies of Georgia Inc., Teleflex Incorporated, Pennine Healthcare, Adapta Medical, and ConvaTec Inc.